Astria Therapeutics (ATXS) PT Raised to $22 at Jefferies
Tweet
Share
E-mailGet Alerts ATXS Hot Sheet
Price: $12.58 --0%
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Rating Summary:
2 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Join SI Premium – FREE
Jefferies analyst Eun Yang raised the price target on Astria Therapeutics (NASDAQ: ATXS) to $22.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- MongoDB (MDB) PT Lowered to $450 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
